Remdesivir to be used in patients with moderate to severe Covid-19: Health ministry

24 December,2021 09:15 PM IST |  New Delhi  |  PTI

The health ministry also warned against the use of the drug in patients who are not on oxygen support or in-home settings

This picture has been used for representational purpose


The Centre said Remdesivir drug should only be used in patients with ‘moderate to severe' Covid-19 and those with no renal or hepatic dysfunction within 10 days of the onset of any symptom.

It also warned against the use of the drug in patients who are not on oxygen support or in-home settings. According to the clinical guidance issued by the Union health ministry for the management of the infection in adult patients, Remdesivir has been asked to be "used in patients with moderate to severe Covid-19 and those with no renal or hepatic dysfunction within 10 days of onset of any symptom".

The Tocilizumab drug may be considered for use in the presence of severe disease (preferably within 24 to 48 hours of onset of severe disease/ICU admission), according to the guidelines. Tocilizumab can be used in case of significantly raised inflammatory markers (CRP &/or IL-6), condition not improving despite use of steroids and no active bacterial/fungal/tubercular infection.

The ministry also said that those above 60 years of age, with cardiovascular disease, hypertension, diabetes and other immunocompromised states are at high risk for severe disease and mortality. According to the guidelines, coronavirus patients have been classified into those affected by mild, moderate and severe disease.

For mild disease, home isolation and care is recommended, while admission in a ward is recommended for those battling moderate disease and ICU has been recommended for patients with severe Covid-19, they added.

Also Read: Maharashtra: 20 new Omicron cases reported, 11 from Mumbai; tally now at 108

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!
Coronavirus national news Omicron
Related Stories